From GLP-1 medications to sustainable habits: realistic, no-hype guidance on weight, appetite and metabolism.
Ozempic, Wegovy, Mounjaro and the new pills: real benefits, real downsides, costs, risks and who should consider them.
Read article
From week 1 to month 16: a realistic Wegovy weight-loss timeline based on trial data, including the new 7.2 mg Wegovy HD.
Read article
Alli is the only FDA-approved OTC option. What about the rest of the shelf? An honest audit of supplements vs evidence.
Read article
Social media's favourite GLP-1 hack, examined: the appeal, the risks of DIY dosing, and the legitimate version doctors use.
Read article
The world's most prescribed diet pill versus its upgraded duo: results, costs, side effects and duration rules.
Read article
Average 20.9 percent loss at 72 weeks: what Zepbound delivers, who responds best and what the averages hide.
Read article
Up to 40 percent of GLP-1 weight loss can be lean mass. The protein targets and training plan that prevent it.
Read article
Patent expiry quietly created the cheapest legitimate entry into GLP-1 therapy. Who it fits and what to check.
Read article
From 0.25 mg to the new 7.2 mg HD, plus the daily pill: every Wegovy dose, why the ladder exists and how adjustments work.
Read article
Why fast weight loss ages the face, whether the drug is to blame, prevention strategies and the options if it already happened.
Read article
Most users regain after stopping. The biology of the rebound, what the successful minority does differently, and the exit plan to build from day one.
Read article
Liraglutide vs semaglutide: results, dosing burden, price and the cases where the older daily pen still makes sense.
Read article
Needle-free GLP-1 arrived in 2026: how the new pills work, trial results, costs and what changes for patients.
Read article
Nausea, fatigue, hair shedding and the rare serious risks of tirzepatide, with management strategies that work.
Read article
The plain-English guide to the weight-loss medications everyone is searching for, and the questions to ask first.
Read article
The constant mental chatter about food, explained: the science, the GLP-1 silence, and evidence-based ways to turn the volume down.
Read article
Oily stools, urgency and the internet's legends: what actually happens on orlistat, why, and how to prevent all of it.
Read article
Cravings pill vs appetite pens: a practical decision guide comparing mechanisms, results, costs and fit.
Read article
Tirzepatide vs semaglutide head to head: trial results, side effects, costs and how the 2026 lineup really stacks up.
Read article
No supplement mimics the pens, but your body makes GLP-1 every day. The foods and habits that genuinely raise it, and the claims to ignore.
Read article
The distinctive side-effect profile of phentermine-topiramate, from paresthesia to the pregnancy rule.
Read article
From nausea and fatigue to rare serious risks: a complete, honest guide to semaglutide side effects, duration and warning signs.
Read article
Nausea, insomnia, the boxed warning and the opioid rule: the complete safety guide to naltrexone-bupropion.
Read article
Muscle loss, hormones, sleep and life stage: why the same habits produce different results after 40.
Read article
Same molecule, different labels: doses, approvals, insurance, results and how doctors actually choose between them.
Read article
Six doses, four-week steps and the logic of tirzepatide titration: how prescribers find your right rung.
Read article
The foods that trigger nausea, the ones that protect muscle, and how to eat well on a suppressed appetite.
Read article
The only OTC-available weight-loss medication: mechanism, honest 3 to 5 percent results and the fat rule that runs everything.
Read article
Average 5 to 8 percent loss at 56 weeks: what Saxenda realistically delivers, for whom, and when it is enough.
Read article
Naltrexone plus bupropion targets cravings in the brain, not hormones in the gut. Who it helps and what to expect.
Read article
Why protein quietly outperforms most weight-loss tricks, and how much you actually need.
Read article
The strongest approved weight-loss pill: mechanism, 8 to 10 percent averages, dosing tiers and who it suits.
Read article
Forget crash diets. The evidence-backed fundamentals of losing weight in a way you can sustain.
Read article
Starvation mode, magic metabolism boosters and other myths, corrected with what the science actually shows.
Read article
How GLP-1 medications changed the weight-loss conversation in the US and UK, and what it means for everyday metabolic health.
Read articleAll content is evidence-informed and for general information only, not medical advice. We may earn an affiliate commission on some links, which never affects our editorial conclusions.
